Nux Moschata Pellet
NDC Package 37662-1925-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Nux Moschata pellets is classified as a

administered via oral route. This formulation utilizes a pellet delivery system. Marketed by Hahnemann Laboratories, Inc., this product is identified by NDC 37662-1925.

Identification & Billing

NDC Package Code
37662-1925-2
Package Description
500 PELLET in 1 VIAL, GLASS
Product Code
37662-1925
11-Digit Billing Format
37662192502

Clinical Specifications

Proprietary Name
Nux Moschata
Non-Proprietary Name
Nux Moschata
Substance Name
Nutmeg
Dosage Form
Pellet - A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
NUTMEG 500 [hp_C]/1
Pharmacologic Class

Regulatory & Marketing

Labeler Name
Hahnemann Laboratories, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
11-14-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (37662-1925). Click a package code to view its specific billing and regulatory data.

37662-1925-1
200 PELLET in 1 VIAL, GLASS
37662-1925-3
3000 PELLET in 1 BOTTLE, GLASS
37662-1925-4
10000 PELLET in 1 BOTTLE, GLASS

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 37662-1925-2 identifies a specific commercial package of 500 pellet in 1 vial, glass of Nux Moschata, a human over the counter drug labeled by Hahnemann Laboratories, Inc.. This pellet is formulated for oral use and contains nutmeg as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hahnemann Laboratories, Inc. on November 14, 2022. The current certification is valid through December 31, 2026.

How is this Hahnemann Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 37662192502. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
37662-1925-2
11-Digit CMS (5-4-2)
37662-1925-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.